No elevated risk for stroke seen after COVID-19 bivalent vaccine receipt
Mar 20, 2024
No evidence was seen for an increased risk for stroke in one- to 21-day or 22- to 42-day windows compared with a 43- to 90-day window after the vaccine.
Education on approval process may increase acceptance of new RSV vaccines
Aug 14, 2023
Just 13% of respondents knew about the existence of an approved vaccine against RSV for older adults. Those educated on vaccine approval process or about potential severity of RSV may be more accepting.